Improving early detection of high-risk pancreatic cysts
Biomarker validation for intraductal papillary mucinous neoplasms of the pancreas
This research aims to find better ways to tell which pancreatic cysts are likely to become cancer, helping doctors decide who needs treatment sooner.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-11095975 on NIH RePORTER |
What this research studies
Pancreatic cysts called IPMN are a chance to stop pancreatic cancer before it starts, but it's hard to know which ones are dangerous. Current tests can't reliably tell the difference between low-risk cysts and those that are likely to turn into aggressive cancer. This project uses a new technology called spatial transcriptomics to look closely at tissue from patients with IPMN. By identifying specific markers in these tissues, we hope to develop more accurate diagnostic tools.
Who could benefit from this research
Good fit: Ideal candidates for future related studies would be patients diagnosed with intraductal papillary mucinous neoplasms (IPMN) of the pancreas.
Not a fit: Patients without IPMN or those with already advanced, invasive pancreatic cancer may not directly benefit from this specific diagnostic research.
Why it matters
Potential benefit: If successful, this work could lead to more accurate tests for pancreatic cysts, allowing for earlier and more precise interventions to prevent pancreatic cancer.
How similar studies have performed: This project utilizes a novel spatial transcriptomics platform to identify specific markers, representing a new approach to distinguish between different types and grades of IPMN.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Allen, Peter J — Duke University
- Study coordinator: Allen, Peter J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.